Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Target cell-specific adenoviral vectors containing E3 and methods of use thereof

Target cell-specific adenoviral vectors containing E3 and methods of use thereof

US Patent 6991935 · Granted Jan 31, 2006

Estimated economic value: $3,234,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PD-1 antibodies2021
PD-1 antibodies2020
Microneedle compositions and methods of using same2019
Microneedle compositions and methods of using same2018
Adenovirus vectors containing cell status-specific response elements and methods2011
Adenovirus vectors containing cell status-specific response elements and methods2011
Adenovirus vectors containing cell status-specific response elements and methods2011
Adenovirus vectors containing cell status-specific response elements and methods2011
Adenovirus vectors containing cell status-specific response elements and methods2009
Adenovirus vectors containing cell status-specific response elements and methods2009
Cell-specific adenovirus vector comprising EBV-specific promoter2008
Metastatic colon cancer specific promoter and uses thereof2008